CNTA
Price
$25.33
Change
-$0.35 (-1.36%)
Updated
Dec 26 closing price
Capitalization
3.74B
89 days until earnings call
Intraday BUY SELL Signals
DNTH
Price
$41.83
Change
-$1.32 (-3.06%)
Updated
Dec 26 closing price
Capitalization
1.79B
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTA vs DNTH

Header iconCNTA vs DNTH Comparison
Open Charts CNTA vs DNTHBanner chart's image
Centessa Pharmaceuticals
Price$25.33
Change-$0.35 (-1.36%)
Volume$465.49K
Capitalization3.74B
Dianthus Therapeutics
Price$41.83
Change-$1.32 (-3.06%)
Volume$319.2K
Capitalization1.79B
CNTA vs DNTH Comparison Chart in %
CNTA
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CNTA vs. DNTH commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a Buy and DNTH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (CNTA: $25.33 vs. DNTH: $41.83)
Brand notoriety: CNTA and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 27% vs. DNTH: 46%
Market capitalization -- CNTA: $3.74B vs. DNTH: $1.79B
CNTA [@Biotechnology] is valued at $3.74B. DNTH’s [@Biotechnology] market capitalization is $1.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileDNTH’s FA Score has 1 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • DNTH’s FA Score: 1 green, 4 red.
According to our system of comparison, DNTH is a better buy in the long-term than CNTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 4 TA indicator(s) are bullish while DNTH’s TA Score has 3 bullish TA indicator(s).

  • CNTA’s TA Score: 4 bullish, 6 bearish.
  • DNTH’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than CNTA.

Price Growth

CNTA (@Biotechnology) experienced а +1.93% price change this week, while DNTH (@Biotechnology) price change was -1.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

CNTA is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTA($3.74B) has a higher market cap than DNTH($1.79B). DNTH YTD gains are higher at: 91.881 vs. CNTA (51.224). DNTH has higher annual earnings (EBITDA): -139.9M vs. CNTA (-227.27M). DNTH has more cash in the bank: 403M vs. CNTA (246M). DNTH has less debt than CNTA: DNTH (1.29M) vs CNTA (118M). CNTA has higher revenues than DNTH: CNTA (15M) vs DNTH (3.08M).
CNTADNTHCNTA / DNTH
Capitalization3.74B1.79B209%
EBITDA-227.27M-139.9M162%
Gain YTD51.22491.88156%
P/E RatioN/A3.24-
Revenue15M3.08M487%
Total Cash246M403M61%
Total Debt118M1.29M9,183%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
22
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
64
SEASONALITY SCORE
1..100
20

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTADNTH
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 23 days ago
84%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 19 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CNTA
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRXUX17.380.04
+0.23%
MFS Blended Research Intl Eq R4
NVLIX56.570.06
+0.11%
Nuveen Winslow Large-Cap Growth ESG I
FMCLX15.24N/A
N/A
Federated Hermes Mid-Cap Index R6
EMAAX17.64N/A
N/A
Gabelli Entpr Mergers & Acquisitions A
ACEIX11.07N/A
N/A
Invesco Equity and Income A

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with CLDX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-1.36%
CLDX - CNTA
44%
Loosely correlated
-1.60%
VRDN - CNTA
43%
Loosely correlated
-1.24%
CGON - CNTA
43%
Loosely correlated
-0.75%
DNTH - CNTA
41%
Loosely correlated
-3.06%
RVMD - CNTA
40%
Loosely correlated
-0.54%
More

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with RVMD. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-3.06%
RVMD - DNTH
47%
Loosely correlated
-0.54%
VRDN - DNTH
47%
Loosely correlated
-1.24%
CGON - DNTH
45%
Loosely correlated
-0.75%
SYRE - DNTH
45%
Loosely correlated
-0.33%
XNCR - DNTH
45%
Loosely correlated
-1.49%
More